Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation

Clinical Cardiology

Volumn 36, Issue 1, 2013, Pages 40-45

  Sang, Cai Hua ^a   Chen, Ke ^b   Pang, Xue Feng ^a   Dong, Jian Zeng ^b   Du, Xin ^b   Ma, Hui ^a   Liu, Ji Hong ^a   Ma, Chang Sheng ^a   Sun, Ying Xian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; PROPAFENONE; SOTALOL;

ADULT; ANXIETY DISORDER; ARTICLE; CATHETER ABLATION; DEPRESSION; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; QUALITY OF LIFE; SELF-RATING ANXIETY SCALE; SELF-RATING DEPRESSION SCALE; SHORT FORM 36;

ANXIETY; ATRIAL FIBRILLATION; CATHETER ABLATION; CHINA; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TACHYCARDIA, PAROXYSMAL;

EID: 84872329226     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22039     Document Type: Article

References (31)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285: 2370-2375.
2. Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000; 36: 1303-1309.
3. Thrall G, Lip GY, Carroll D, et al. Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest. 2007; 132: 1259-1264.
4. Gehi AK, Sears S, Goli N, et al. Psychopathology and symptoms of atrial fibrillation: implications for therapy. J Cardiovasc Electrophysiol. 2012; 23: 473-478.
5. Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010; 303: 333-340.
6. Dorian P, Paquette M, Newman D, et al. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J. 2002; 143: 984-990.
7. Sang C, Jiang C, Dong J, et al. A new method to evaluate linear block at the left atrial roof: is it reliable without pacing? J Cardiovasc Electrophysiol. 2010; 21: 741-746.
8. Dong J, Liu X, Long D, et al. Single-catheter technique for pulmonary vein antrum isolation: is it sufficient to identify and close the residual gaps without a circular mapping catheter? J Cardiovasc Electrophysiol. 2009; 20: 273-279.
9. Fuster V, Rydén LE, Cannom DS, et al. 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 123: e269-e367.
10. Zung WW., A self-rating depression scale. Arch Gen Psychiatry. 1965; 12: 63-70.
11. Zung WW., A rating instrument for anxiety disorders. Psychosomatics. 1971; 12: 371-379.
12. Liu XC, Oda S, Peng X, et al. Life events and anxiety in Chinese medical students. Soc Psychiatry Psychiatr Epidemiol. 1997; 32: 63-67.
13. Fang Y, Yuan C, Xu Y, et al. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population. J Clin Psychopharmacol. 2010; 30: 357-364.
14. McHorney CA Jr, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993; 31: 247-263.
15. Wang R, Wu C, Zhao Y, et al. Health related quality of life measured by SF-36: a population-based study in Shanghai, China. BMC Public Health. 2008; 8: 292.
16. Li L, Wang HM, Shen Y., Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health. 2003; 57: 259-263.
17. Lam CL, Tse EY, Gandek B, et al. The SF-36 summary scales were valid, reliable, and equivalent in a Chinese population. J Clin Epidemiol. 2005; 58: 815-822.
18. Huffman JC, Smith FA, Blais MA, et al. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Am J Cardiol. 2006; 98: 319-324.
19. Shen BJ, Avivi YE, Todaro JF, et al. Anxiety characteristics independently and prospectively predict myocardial infarction in men the unique contribution of anxiety among psychologic factors. J Am Coll Cardiol. 2008; 51: 113-119.
20. Vaccarino V, Johnson BD, Sheps DS, et al. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol. 2007; 50: 2044-2050.
21. Jiang W, Kuchibhatla M, Cuffe MS, et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation. 2004; 110: 3452-3456.
22. Rutledge T, Reis VA, Linke SE, et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006; 48: 1527-1537.
23. Lane DA, Langman CM, Lip GY, et al. Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. J Psychosom Res. 2009; 66: 203-210.
24. Guédon-Moreau L, Capucci A, Denjoy I, et al. Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life. Europace. 2010; 12: 634-642.
25. Pappone C, Rosanio S, Augello G, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol. 2003; 42: 185-197.
26. Pürerfellner H, Martinek M, Aichinger J, et al. Quality of life restored to normal in patients with atrial fibrillation after pulmonary vein ostial isolation. Am Heart J. 2004; 148: 318-325.
27. Themistoclakis S, Corrado A, Marchlinski FE, et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol. 2010; 55: 735-743.
28. Oral H, Chugh A, Ozaydin M, et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation. 2006; 114: 759-765.
29. Nademanee K, Schwab MC, Kosar EM, et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2008; 51: 843-849.
30. Hussein AA, Saliba WI, Martin DO, et al. Natural History and long-term outcomes of ablated atrial fibrillation. Circ Arrhythm Electrophysiol. 2011; 4: 271-278.
31. Wokhlu A, Monahan KH, Hodge DO, et al. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect. J Am Coll Cardiol. 2010; 55: 2308-2316.